Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Zepp Health Q3 Adj. EPADS $(0.35) Misses $0.03 Estimate, Sales $82.50M Miss $179.52M Estimate

Author: Benzinga Newsdesk | November 20, 2023 06:20am
Zepp Health (NYSE:ZEPP) reported quarterly losses of $(0.35) per share which missed the analyst consensus estimate of $0.03 by 1266.67 percent. This is a 1650 percent decrease over losses of $(0.02) per share from the same period last year. The company reported quarterly sales of $82.50 million which missed the analyst consensus estimate of $179.52 million by 54.04 percent. This is a 51.33 percent decrease over sales of $169.51 million the same period last year.

Posted In: ZEPP


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist